Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Controlled trial of the efficacy and safety of valproate, versus risperidone in children,
ages 3-7 yr. with Bipolar I or II Disorder, mixed, manic or hypomanic episode.